May 18, 2016

Appointment of Dr. Maureen M. Goodenow as Associate Director for AIDS Research, NIH

I am pleased to announce the selection of Maureen M. Goodenow, Ph.D., as NIH Associate Director for AIDS Research and Director of the NIH Office of AIDS Research (OAR). Dr. Goodenow brings nearly 30 years of experience in HIV/AIDS research and advocacy to the position. She is expected to join NIH in July 2016 to lead OAR’s efforts, working closely with the NIH institutes and centers, to pursue new tools for preventing HIV infection including a vaccine, improved treatments, and ultimately, a cure.

Dr. Goodenow comes to us from the University of Florida, Gainesville, where she is a professor of pathology, immunology, and laboratory medicine. There she has held the Stephany W. Holloway University Endowed Chair for AIDS Research since 2004. She also is the Director of the Center for Research in Pediatric Immune Deficiency. She leads a research program in molecular epidemiology, pathogenesis, and vaccines for HIV-1 and related viruses, including viruses that cause cancer. Dr. Goodenow has published over 100 articles and book chapters, and trained more than 25 doctoral and postdoctoral fellows.

She received her Ph.D. in molecular genetics from the Albert Einstein College of Medicine in New York. Following a postdoctoral fellowship in molecular oncology at the Sloan Kettering Institute in New York, she was a visiting scientist at the Pasteur Institute in Paris, where she began her studies of HIV.

Dr. Goodenow has previously served NIH ably on multiple NIH advisory committees, including the AIDS Research Advisory Committee for the Division of AIDS at the National Institute of Allergy and Infectious Diseases, and the OAR advisory committee for the Trans-NIH Plan for HIV-Related Research. She also advised a joint program between NIH and the U.S. Department of State to enhance research between U.S. and Russian scientists, and advised the Fogarty International Center on programs in India and Kazakhstan.

Recently, Dr. Goodenow has played an important role in international AIDS efforts as the Acting Director of the Office for Research and Science within the U.S. Department of State, Office of the U.S. Global AIDS Coordinator and Office of Global Health Diplomacy. There she has been overseeing combination prevention trials funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She also served from 2012-2013 as a senior science advisor and Jefferson Science Fellow in the Department of State Bureau of East Asian and Pacific Affairs, Office of Economic Policy.

I want to express my sincerest gratitude to Robert W. Eisinger, Ph.D., for leading OAR with skill and dedication over the past year through this time of transition.

Please join me in welcoming Maureen Goodenow to NIH.

Francis S. Collins, M.D., Ph.D.
Director, National Institutes of Health